RxDoctor Payments Data

Veena Kalra, MD

Gynecology · Flint, MINPI 1942200977

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,157 of the $1,791 with a category attached, or 64.6%. 12 manufacturers reported payments, led by Acessa Health Inc. at 42.9% of the total. Reporting peaked in 2021 at $834 and has fallen 76.1% since, to $199 in 2025.

$1,791in general payments, 2019–2025

Across 39 payments — averaging $45.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acessa Health Inc.$768
  • Medtronic$294
  • Coopersurgical, Inc.$165
  • Sumitomo Pharma America, Inc.$148
  • AbbVie$125
  • Covidien LP$94
  • plus $197 from 6 others
$1,237,428in research payments, 2019–2025

Across 50 payments — averaging $24,749 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Evofem Biosciences, Inc.$1.2M
  • GSK$34K

What the payments were for

  • Travel & lodging$63435%
  • Food & beverage$1,15765%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,791 in reported general payments places this provider in the 75th percentile of 50 gynecology providers in Michigan.

See all gynecology providers in Michigan

Medicare billing

Part B allowed, 2024
$8,211
Medicare patients
36
Services billed
91

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol40$1,991
Clobetasol Propionate38$658
ValacyclovirValacyclovir Hcl11$411
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip25$405
Fluconazole19$83

Paid to pharmacies, not to this prescriber.

Other gynecology in Flint

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →